Hoitt Jason
Stoke Therapeutics, Inc. · Chief Patient Officer
Hoitt Jason is listed in filings as Chief Patient Officer at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 19, 2026, including sale activity. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK). The current snapshot covers public activity from Feb 19, 2026 to Mar 19, 2026. Reported amounts are shown as $4.4K to $55.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $34k1k shares | SellMar 17, 2026 | $32.74 | $29.11 | |
| $25k748 shares | SellMar 17, 2026 | $33.38 | $29.11 |